New ORWH Notice of Funding Opportunity (R01 Research Project Grant)
ORWH recently released Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional) to support research on chronic conditions that affect women and individuals assigned female at birth. Applications are being accepted through June 20, 2023.
New ORWH Notice of Funding Opportunity (R21 Exploratory/Development Research Grant)
ORWH recently released Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) to support research on chronic conditions that affect women and individuals assigned female at birth. Applications are being accepted through June 20, 2023.
The 7th Annual Vivian W. Pinn Symposium honors the first full-time director of ORWH, Dr. Vivian Pinn, and is held during National Women’s Health Week. The title of this year’s symposium is “Menopause and Optimizing Midlife Health of Women.” The event will take place on Tuesday, May 16, 2023.
Request for Applications: An Advancing Gender Inclusive Excellence (AGIE) Coordinator Center
ORWH and the National Institute of Diabetes and Digestive and Kidney Diseases recently re-issued a request for applications for an Advancing Gender Inclusive Excellence (AGIE) Coordinator Center. Applications are being accepted through May 31, 2023.
ORWH’s In Focus Publication Explores Disparities and Workforce Diversity in Mental Health
The latest issue of Women’s Health in Focus at NIH explores disparities and workforce diversity in mental health. The feature story discusses mental health disparities, the lack of diversity in the mental health workforce, and Federal initiatives addressing these issues.
Janine Austin Clayton, M.D., FARVO
Janine Austin Clayton, M.D., FARVO, was appointed Associate Director for Research on Women’s Health and Director of the Office of Research on Women’s Health at the National Institutes of Health (NIH) in 2012. Dr. Clayton has strengthened NIH support for research on diseases, disorders, and conditions that affect women. She is the architect of the NIH policy requiring scientists to consider sex as a biological variable across the research spectrum, including research designs, analyses, and reporting in vertebrate animal and human studies. The policy serves as the keystone of NIH's initiative to enhance research reproducibility, rigor, and transparency.
Featured NIH-Wide Resources & Initiatives
A public-private partnership to develop a coordinated research strategy to speed the most promising COVID-19 vaccines and treatments.
A new science agency proposed by President Joseph Biden as part of NIH to drive biomedical breakthroughs and provide transformative solutions for all patients.
All of Us Research Program
A research effort to revolutionize how we improve health and treat disease.
Accelerating Medicines Partnership
A bold venture to help identify new treatments and cures for diseases.
Rapid Acceleration of Diagnostics (RADx)
An initiative to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.
NIH does not tolerate pervasive or severe harassment of any kind, including sexual harassment.
NIH HEAL Initiative
Trans-agency effort to speed scientific solutions to stem the national opioid crisis.
Impact of NIH Research
NIH-supported research has had a major positive impact on nearly all of our lives.
A new research initiative to understand, prevent, and treat the long-term effects of COVID-19.
Ending Structural Racism
Learn more about NIH’s efforts to end structural racism in biomedical research through the UNITE initiative.
Learn about participating in clinical trials and where to find them.
Medical Research Initiatives
Important initiatives aimed at improving medical research.